Heterohybridomas secreting human monoclonal antibodies against Haemophilus influenzae type b. 1988

D Martin, and Y Larose, and J Hamel, and J Lagacé, and B R Brodeur
Hybridoma Section, Bureau of Microbiology, Laboratory Centre for Disease Control, Ottawa, Canada.

Seven human monoclonal antibodies (HmAb) directed against outer membrane antigens of Haemophilus influenzae type b (Hib) were produced by fusing Sp2/HPT heteromyeloma cells with human tonsillar lymphocytes sensitized in vitro for 6 days. The heterohybridomas were maintained in culture for at least one year and secreted, when cultured in Dulbecco's modified Eagle's medium without fetal calf serum, between 1 and 15 micrograms/10(6) cells/ml/24 h. All of the HmAb were IgGs except HiH-12 which is an IgM. Antibodies directed against the lipopolysaccharide and proteins of apparent molecular masses of 43, 37 and 27 kDa were identified by immunoblotting of sodium dodecyl sulfate-polyacrylamide gel electrophoresis patterns of outer membrane. Binding radioimmunoassay with live bacteria showed that five out of seven HmAb adsorbed to cell surface-exposed antigenic determinants. HmAb HiH-6, HiH-7 and HiH-10 reacted with a surface-accessible determinant on the 43-kDa outer membrane protein. In a dot enzyme immunoassay, these HmAb recognized 103 out of 111 Hib strains isolated worldwide. The strains were selected to represent the most common genotypic variations among Hib. None of these HmAb reacted with other bacterial species tested. These HmAb may serve to study the bacterial surface antigens implicated in the human humoral response and protection to Hib infections.

UI MeSH Term Description Entries
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D006193 Haemophilus influenzae A species of HAEMOPHILUS found on the mucous membranes of humans and a variety of animals. The species is further divided into biotypes I through VIII. Bacterium influenzae,Coccobacillus pfeifferi,Haemophilus meningitidis,Hemophilus influenzae,Influenza-bacillus,Mycobacterium influenzae
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000907 Antibodies, Bacterial Immunoglobulins produced in a response to BACTERIAL ANTIGENS. Bacterial Antibodies
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D000918 Antibody Specificity The property of antibodies which enables them to react with some ANTIGENIC DETERMINANTS and not with others. Specificity is dependent on chemical composition, physical forces, and molecular structure at the binding site. Antibody Specificities,Specificities, Antibody,Specificity, Antibody
D001425 Bacterial Outer Membrane Proteins Proteins isolated from the outer membrane of Gram-negative bacteria. OMP Proteins,Outer Membrane Proteins, Bacterial,Outer Membrane Lipoproteins, Bacterial
D066298 In Vitro Techniques Methods to study reactions or processes taking place in an artificial environment outside the living organism. In Vitro Test,In Vitro Testing,In Vitro Tests,In Vitro as Topic,In Vitro,In Vitro Technique,In Vitro Testings,Technique, In Vitro,Techniques, In Vitro,Test, In Vitro,Testing, In Vitro,Testings, In Vitro,Tests, In Vitro,Vitro Testing, In

Related Publications

D Martin, and Y Larose, and J Hamel, and J Lagacé, and B R Brodeur
January 1992, Scandinavian journal of immunology,
D Martin, and Y Larose, and J Hamel, and J Lagacé, and B R Brodeur
January 2000, Microbial pathogenesis,
D Martin, and Y Larose, and J Hamel, and J Lagacé, and B R Brodeur
February 1995, Australian journal of public health,
D Martin, and Y Larose, and J Hamel, and J Lagacé, and B R Brodeur
September 1992, Communicable disease report. CDR weekly,
D Martin, and Y Larose, and J Hamel, and J Lagacé, and B R Brodeur
May 1986, Lancet (London, England),
D Martin, and Y Larose, and J Hamel, and J Lagacé, and B R Brodeur
March 1984, Journal of general microbiology,
D Martin, and Y Larose, and J Hamel, and J Lagacé, and B R Brodeur
April 1982, Infection and immunity,
D Martin, and Y Larose, and J Hamel, and J Lagacé, and B R Brodeur
January 1971, Acta pathologica et microbiologica Scandinavica. Section B: Microbiology and immunology,
D Martin, and Y Larose, and J Hamel, and J Lagacé, and B R Brodeur
January 2006, Methods in enzymology,
D Martin, and Y Larose, and J Hamel, and J Lagacé, and B R Brodeur
June 1990, Pediatric clinics of North America,
Copied contents to your clipboard!